Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy.
Rajaram V, Pandhya S, Patel S, Meyer PM, Goldin M, Feinstein MJ, Neems R, Liebson PR, Fiedler BM, Macioch JE, Feinstein SB.
Am J Cardiol. 2004 Jun 3;93(11A):32C-48C. Review.PMID: 15178515 [PubMed - indexed for MEDLINE]Related articles